Makaleler

Tümü (6)

SCI-E, SSCI, AHCI (6)

SCI-E, SSCI, AHCI, ESCI (6)

Scopus (6)

2018

2018

1. Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.

BOZKURT S., DAGCINAR A., TANRIKULU B., Comunoglu N., MEYDAN B., OZEK M., et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery , cilt.34, ss.107-116, 2018 (SCI-Expanded)

2006

2006

2. Effects of valsartan on stress-induced changes of serum vascular endothelial growth factor and nitric oxide in mice

Erbas B., Uresin Y., Ozek M., Dogru-Abbasoglu S.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.116, sa.5, ss.601-611, 2006 (SCI-Expanded)

2004

2004

3. Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress

URESIN Y., ERBAS B., OZEK M., OZKOK E., Gurol A. O.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.5, sa.2, ss.93-96, 2004 (SCI-Expanded, Scopus)

2003

2003

4. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice

Ozek M., Uresin Y., Gungor M.

LIFE SCIENCES , cilt.72, sa.17, ss.1943-1951, 2003 (SCI-Expanded)

2002

2002

5. Protective effects of dextromethorphan and tizanidine on ouabain-induced arrhythmias

Uresin Y., Ozek M., Sevgi S.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.24, sa.7, ss.421-423, 2002 (SCI-Expanded)

2000

2000

6. Therapeutic drug monitoring in Turkey: Experiences from Istanbul

Yamanturk P., OZEK M., SEVGI S., EROGLU L.

THERAPEUTIC DRUG MONITORING , cilt.22, sa.5, ss.545-548, 2000 (SCI-Expanded)